Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways.

MLA

Yu, Min, et al. “Paeoniflorin Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Suppressing TAK1-MAPK/NF-ΚB Pathways.” International Journal of Medical Sciences, vol. 19, no. 4, Mar. 2022, pp. 681–94. EBSCOhost, https://doi.org/10.7150/ijms.69289.

APA

Yu, M., Wu, X., Wang, J., He, M., Han, H., Hu, S., Xu, J., Yang, M., Tan, Q., Wang, Y., Wang, H., Xie, W., & Kong, H. (2022). Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways. International Journal of Medical Sciences, 19(4), 681–694. https://doi.org/10.7150/ijms.69289

Chicago

Yu, Min, Xuecheng Wu, Jingjing Wang, Mengyu He, Honghao Han, Song Hu, Jian Xu, et al. 2022. “Paeoniflorin Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Suppressing TAK1-MAPK/NF-ΚB Pathways.” International Journal of Medical Sciences 19 (4): 681–94. doi:10.7150/ijms.69289.